Cargando…
Implantable hyaluronic acid-deferoxamine conjugate prevents nonunions through stimulation of neovascularization
Approximately 6.3 million fractures occur in the U.S. annually, with 5–10% resulting in debilitating nonunions. A major limitation to achieving successful bony union is impaired neovascularization. To augment fracture healing, we designed an implantable drug delivery technology containing the angiog...
Autores principales: | Donneys, Alexis, Yang, Qiuhong, Forrest, Marcus Laird, Nelson, Noah S., Zhang, Ti, Ettinger, Russell, Ranganathan, Kavitha, Snider, Alicia, Deshpande, Sagar S., Cohen, Mark S., Buchman, Steven R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529413/ https://www.ncbi.nlm.nih.gov/pubmed/31123600 http://dx.doi.org/10.1038/s41536-019-0072-9 |
Ejemplares similares
-
Abstract: Implantable Deferoxamine Facilitates Non-Vascularized Grafting in Irradiated Bone
por: Donneys, Alexis, et al.
Publicado: (2017) -
Abstract 105: Deferoxamine: A Regenerative Therapeutic with Antitumorigenic Potential
por: Donneys, Alexis, et al.
Publicado: (2018) -
Abstract: Antitumorigenic Effect of Deferoxamine on Human Head and Neck Cancer Cell Proliferation
por: Donneys, Alexis, et al.
Publicado: (2018) -
Abstract: Deferoxamine Increases Breast Cancer Radiosensitivity
por: Ranganathan, Kavitha, et al.
Publicado: (2018) -
Abstract: Remediation of Radiation Associated Vasculopathy Utilizing a Novel Angiogenic Nanotechnology
por: Snider, Alicia Elizabeth, et al.
Publicado: (2017)